Not yet recruitingPhase 3NCT06613997

21-day Double-blind Trial of Albendazole in Adults With Loa Loa Microfilaremia

Studying Loiasis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Programme National de Lutte contre l'Onchocercose, Republic of the Congo
Principal Investigator
Jéremy CAMPILLO, PharmD PhD
Institut de Recherche pour le Développement (IRD)
Intervention
Albendazole 400mg(drug)
Enrollment
100 enrolled
Eligibility
18-70 years · All sexes
Timeline
2025 – 2027

Collaborators

Institut de Recherche pour le Developpement

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06613997 on ClinicalTrials.gov

Other trials for Loiasis

Additional recruiting or active studies for the same condition.

See all trials for Loiasis →

← Back to all trials